Sat.Mar 09, 2024 - Fri.Mar 15, 2024

article thumbnail

Scientists generate new targeted protein degradation system that tunes a cell’s own proteins

Broad Institute

Scientists generate new targeted protein degradation system that tunes a cell’s own proteins By Leah Eisenstadt March 14, 2024 Breadcrumb Home Scientists generate new targeted protein degradation system that tunes a cell’s own proteins Researchers have engineered a compact degron tag that can be precisely edited into a cell’s genome, enabling scientists to trigger the rapid breakdown of native target proteins.

article thumbnail

Milk to the rescue for diabetics? Cow produces human insulin in milk

Science Daily: Pharmacology News

An unassuming brown bovine from the south of Brazil has made history as the first transgenic cow capable of producing human insulin in her milk. The advancement could herald a new era in insulin production, one day eliminating drug scarcity and high costs for people living with diabetes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Madrigal wins FDA approval of first drug for MASH

BioPharma Drive: Drug Pricing

Rezdiffra’s clearance is a turning point in the fight against the liver disease. But its sales potential is unclear, and competition could emerge from popular weight loss drugs.

article thumbnail

What do volunteers for research studies do after finding a trial?

Antidote

For many people, participating in a research study presents an interesting opportunity with many benefits to volunteering. While there are many types of clinical research, all with distinct goals and timelines, trial volunteers will follow a similar path when taking part. Read on to learn more about the process.

Trials 119
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Zepbound Helps Obese People Shed Pounds, Regardless of Starting Weight

Drugs.com

THURSDAY, March 14, 2024 -- The blockbuster weight-loss medication Zepbound (tirzepatide) appears to help folks quickly shed pounds regardless of how overweight they are, or how long they've lived being overweight or obese. Those are the findings.

116
116
article thumbnail

A healthier diet is linked with a slower pace of aging, reduced dementia risk, study shows

Science Daily: Pharmacology News

A healthier diet is associated with a reduced dementia risk and slower pace of aging, according to a new study. The findings show that a diet-dementia association was at least partially facilitated by multi-system processes of aging. Until now, the biological mechanism of this protection was not well understood.

131
131

More Trending

article thumbnail

7 things to know about multiple sclerosis

Antidote

Receiving a multiple sclerosis (MS) diagnosis can feel overwhelming and isolating for many. MS is a neurodegenerative disease that often involves challenging symptoms — but knowing what to expect and what resources are available can help.

Disease 116
article thumbnail

Vitamin D Plus Calcium: Good News, Bad News for Older Women

Drugs.com

TUESDAY, March 12, 2024 -- Women who've gone through menopause and hope that supplemental vitamin D plus calcium might shield them from disease may be disappointed by new data.A follow-up analysis of data from the landmark Women's Health Initiative.

Disease 116
article thumbnail

Drought, soil desiccation cracking, and carbon dioxide emissions: an overlooked feedback loop exacerbating climate change

Science Daily: Pharmacology News

Soil stores 80 percent of carbon on earth, yet with increasing cycles of drought, that crucial reservoir is cracking and breaking down, releasing even more greenhouse gases creating an amplified feedback loop that could accelerate climate change.

122
122
article thumbnail

Madrigal, FDA approval in hand, outlines plan to sell MASH drug

BioPharma Drive: Drug Pricing

The company expects initial uptake of Rezdiffra, which costs $47,400 per year, to be slow as doctors and insurers establish the protocols needed to find patients eligible for treatment.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Ubiquitous pyrogens and 3D cancer models

Drug Target Review

A collaboration between the University of Twente in the Netherlands and Rousselot has revealed the dynamics between biomaterial purity and the fidelity of 3D cancer models. Their joint study illuminated the profound impact of endotoxins on the accuracy and efficacy of these models, marking a significant breakthrough in cancer research. Through experimentation, contrasting research-grade gelatine, inherently infused with endotoxins, with an ultra-low endotoxin-level gelatine, they revealed that t

article thumbnail

Four Key Takeaways from TrailblazerDX

Perficient: Drug Development

Last week, I attended TrailblazerDX in San Francisco, where the content was all about Salesforce Data Cloud and AI! There were over 300 sessions to attend, from technical talks to hands-on workshops where attendees could learn how to build copilots and how to use the latest Salesforce platform features directly from product managers , architects, and fellow developers.

article thumbnail

An electricity generator inspired by the drinking bird toy powers electronics with evaporated water

Science Daily: Pharmacology News

Inspired by the classic drinking bird toy, scientists have developed an engine that efficiently converts energy from water evaporation into electricity to power small electronics. The device produces energy outputs exceeding 100 volts -- much higher than other techniques that generate electricity from water -- and can operate for several days using only 100 milliliters of water as fuel, according to a new study.

article thumbnail

After surprise trial failure, ALS doctors brace for one less treatment option

BioPharma Drive: Drug Pricing

Physicians are preparing for tough conversations with patients on Amylyx Pharmaceuticals’ drug, Relyvrio, while holding out hope it still may help some with the disease.

Doctors 125
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Bile acids and the microbiome: revolutionising disease approaches

Drug Target Review

Scientists from the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego have discovered thousands of bile acids. The study’s findings offer new insights into the biochemical language microbes use to influence distant organ systems, which could revolutionise the way researchers approach disease. Dr Pieter Dorrestein, senior author, professor at the Skaggs School and professor of pharmacology and paediatrics at UC San Diego School of Medicine, stated: “B

Disease 111
article thumbnail

#ScienceSaturday: March 9, 2024

KIF1A

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Meet our Guest Bloggers! This spring we’ve been quite fortunate to be joined by 6 Master’s students from Columbia University, who have been contributing to our creation of community resources as part of the

article thumbnail

Alaska dinosaur tracks reveal a lush, wet environment

Science Daily: Pharmacology News

A large find of dinosaur tracks and fossilized plants and tree stumps in far northwestern Alaska provides new information about the climate and movement of animals near the time when they began traveling between the Asian and North American continents roughly 100 million years ago.

121
121
article thumbnail

German biotech Tubulis cashes in on ADC ‘momentum’ with €128M financing

BioPharma Drive: Drug Pricing

The funding for the startup, which partnered with Bristol Myers Squibb last year, adds to a surge of recent investments in developers of antibody-drug conjugates.

Drugs 126
article thumbnail

Poor Trial Results May Prompt Maker to Pull ALS Drug, Relyvrio, From Market

Drugs.com

MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a.

Marketing 115
article thumbnail

Driving efficiency across upstream bioprocess workflow

Drug Target Review

The discovery and development phases of biotherapeutic drugs leverage multiple technologies and processes across upstream and downstream stages of the bioprocess workflow. Advancements in cell line development (CLD), including screening and selection of final clones, scale up, automation and digitalisation have enabled precision and enhanced productivity.

article thumbnail

A new world of 2D material is opening up

Science Daily: Pharmacology News

Materials that are incredibly thin, only a few atoms thick, exhibit unique properties that make them appealing for energy storage, catalysis and water purification. Researchers have now developed a method that enables the synthesis of hundreds of new 2D materials.

Research 118
article thumbnail

Amylyx CEOs look for a path forward following major setback

BioPharma Drive: Drug Pricing

Justin Klee and Joshua Cohen spoke to BioPharma Dive about the next steps for their company, which is considering pulling its only product from market after the drug failed a confirmatory study in ALS.

article thumbnail

Precautions Needed When Folks Taking Ozempic, Wegovy Undergo Anesthesia

Drugs.com

WEDNESDAY, March 13, 2024 — Nurses who specialize in anesthesia have issued new guidelines to reduce the risk that patients taking weight-loss drugs like Ozempic or Wegovy throw up during surgery."These medications have exploded in.

Nurses 111
article thumbnail

The Event-Driven Data Layer: Unifying Analytics and Development Teams

Perficient: Drug Development

One common way of implementing tags through Adobe Launch is using a data layer, which is a JSON object (key/value pair) that is loaded onto the page from which attributes are passed through as the user navigates through the website or completes certain objectives. This can be extended further into using an Event-Driven Data Layer (EDDL), which serves to load Custom Events within JavaScript that are passed to the data layer upon an action being completed on the website, and can be loaded on any e

105
105
article thumbnail

Supply chain disruptions will further exacerbate economic losses from climate change

Science Daily: Pharmacology News

Global GDP loss from climate change will increase exponentially the warmer the planet gets when its cascading impact on global supply chains is factored in, finds a new study.

115
115
article thumbnail

BIO changes stance, backs bill to limit China’s role in US biotech

BioPharma Drive: Drug Pricing

Pressed by lawmakers, the lobbying group is also “taking steps” to end its relationship with Wuxi-AppTec, a major contract manufacturer to the biopharmaceutical industry.

117
117
article thumbnail

Use of Legal 'Delta-8-THC' Is Rising Among Teens - Is it Safe?

Drugs.com

TUESDAY, March 12, 2024 -- They're cheap, easy to buy and now new research shows they have become the buzz of choice for American teens. Delta-8-THC products, which include gummies and vapes, are legal in 22 states and Washington, D.C. There is no.

article thumbnail

AI (Artificial Intelligence) Powered Product People

Perficient: Drug Development

AI (Artificial Intelligence) Powered Product People Have you ever wondered how artificial intelligence can transform not only our lives but also our professions? As someone passionate about technology and digital product development, I have always been intrigued by new tools and how they can improve our lives and careers. In recent times, artificial intelligence (AI) has captured my attention.

article thumbnail

Nasa’s Webb, Hubble telescopes affirm universe’s expansion rate, puzzle persists

Science Daily: Pharmacology News

When you are trying to solve one of the biggest conundrums in cosmology, you should triple check your homework. The puzzle, called the 'Hubble Tension,' is that the current rate of the expansion of the universe is faster than what astronomers expect it to be, based on the universe's initial conditions and our present understanding of the universe's evolution.

113
113
article thumbnail

Boehringer, Sosei Heptares team up in schizophrenia drug deal

BioPharma Drive: Drug Pricing

Sosei Heptares could receive more than 700 million euros in a deal to develop medicines aimed at the protein GPR52, an emerging drug target in multiple neurological diseases.

Drugs 113
article thumbnail

ADHD Meds Cut Odds for Early Death, Especially by Overdose

Drugs.com

TUESDAY, March 12, 2024 -- People diagnosed with attention-deficit hyperactivity disorder (ADHD) show a marked decline in their two-year risk for death once they start taking medication, new research shows. That was particularly true for deaths due.

Research 105
article thumbnail

Perficient Achieves Government Specialization Distinction with Pegasystems

Perficient: Drug Development

Perficient is excited to announce that we have earned the Government Specialization Distinction (Americas) in the new Pega Partners program. Specialized partners are thoroughly vetted by Pega to bring deep vertical knowledge or specialized expertise to clients. Pega Partners that achieve a Specialization have a demonstrated ability to help customers build more innovative businesses, and have a significant impact on their customers, stakeholders, and their partners.

article thumbnail

New AI technology enables 3D capture and editing of real-life objects

Science Daily: Pharmacology News

Imagine performing a sweep around an object with your smartphone and getting a realistic, fully editable 3D model that you can view from any angle -- this is fast becoming reality, thanks to advances in AI. Researchers have unveiled new AI technology for doing exactly this. Soon, rather than merely taking 2D photos, everyday consumers will be able to take 3D captures of real-life objects and edit their shapes and appearance as they wish, just as easily as they would with regular 2D photos today.

Research 112
article thumbnail

Roche, following setbacks, turns to its next Alzheimer’s drug

BioPharma Drive: Drug Pricing

Roche said its experimental Alzheimer’s disease drug trontinemab showed it might be able to clear brain plaques faster than other medicines.

Drugs 117